Profusa ($PFSA) shares down 40% to $1.10. Company signs LOI for $30M acquisition to scale its diagnostics and monitoring business.
Profusa, Inc. (NASDAQ:PFSA) shares tumbled during Tuesday’s trading session.
Strategic Expansion Into Molecular Diagnostics
On Monday, Profusa said it signed a Letter of Intent to acquire BioInsights’ PanOmics multi-omics diagnostics platform in an a… [1919 chars]
Source: Benzinga | Published: 2026-04-07T15:01:38Z
Credit: Benzinga
